{"prompt": "['Alliance A171601', '15.0', 'GENERAL REGULATORY CONSIDERATIONS AND CREDENTIALING', '15.1 Geriatric Assessment Training', 'At each participating site, a research nurse or clinical research professional (CRP) (person who', 'intends to administer the geriatric assessment) will receive training on administration of the', 'geriatric assessment using the online video training module through the Alliance website,', 'hyperlink below:', 'To login, select \"Member Login\" on the Alliance homepage and enter the CTEP-IAM account', 'username and password. After logging in, the training module can be found under education and', 'training > online training and under \"For Site Staff.\" Once the training is complete, print a copy', 'of the completion certificate to keep in the study records and submit it to CTSU according to', 'Section 4.2.3. Training completed within the past two years is acceptable, as it is not study', 'specific.', 'Any further questions or concerns regarding administering the geriatric assessment may be', 'directed to the study chair.', '76', 'NCIVersion Date: 5/29/2020', 'Update 5']['Alliance A171601', '16.0', 'REFERENCES', '1.', 'Finn RS, Crown JP, Lang I, et al: The cyclin-dependent kinase 4/6 inhibitor palbociclib in', 'combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-', 'positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase', '2', 'study. Lancet Oncol 16:25-35, 2015', '2.', 'Turner NC, Ro J, Andre F, et al: Palbociclib in Hormone-Receptor-Positive Advanced Breast', 'Cancer. N Engl J Med 373:209-19, 2015', '3.', 'Hurria A, Gupta S, Zauderer M, et al: Developing a cancer-specific geriatric assessment. Cancer', '104:1998-2005, 2005', '4.', 'Hurria A, Cirrincione CT, Muss HB, et al: Implementing a geriatric assessment in cooperative', 'group clinical cancer trials: CALGB 360401. J Clin Oncol 129:1290-6, 2011', '5.', 'Hurria A, Togawa K, Mohile SG, et al: Predicting chemotherapy toxicity in older adults with', 'cancer: a prospective multicenter study. J Clin Oncol29:3457-65, 2011', '6.', 'Hurria A, Dale W, Mooney M, et al: Designing therapeutic clinical trials for older and frail adults', 'with cancer: U13 conference rec commendations. J Clin Oncol 32:2587-94, 2014', '7.', 'Hurria A, Naylor M, Cohen HJ: Improving the quality of cancer care in an aging population:', 'recommendations from an IOM report. JAMA 310:1795-6, 2013', '8.', 'Sawhney R, Sehl M, Naeim A: Physiologic aspects of aging: impact on cancer management and', 'decision making, part I. Cancer J 11:449-460, 2005', '9.', 'Sehl M, Sawhney R, Naeim A: Physiologic aspects of aging: impact on cancer management and', 'decision making, part II. Cancer J 11:461-473, 2005', '10.', 'Duthie E: Comprehensive Geriatric Oncology, Taylor and Francis, 2004', '11.', 'Yuen G: Altered pharmacokinetics in the elderly. Clin Geratr Med 6:257-267, 1990', '12.', 'Baker S, Grochow L: Pharmacology of chemotherapy in the older person. Clin Geratr Med', '13:169-183, 1997', '13.', 'Kastrissios H, Blaschke T: Medication compliance as a feature in drug development. Annu Rev', 'Pharmacol Toxico 37:451-475, 1997', '14.', 'Vestal RE: Aging and pharmacology. Cancer 80:1302-1310, 1997', '15.', 'Baker S, van Schaik R, Rivory L, et al: Factors affecting cytochrome P-450 activity in cancer', 'patients. Clin Cancer Res 10:8341-8350, 2004', '16.', 'Sotaniemi E, Arranto A, Pelkonen O, et al: Age and cytochrome P450-linked drug metabolism in', 'humans: an analysis of 226 subjects with equal histopathological conditions. Clin Pharmacol Ther', '61:331-339, 1997', '17.', 'Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of', 'kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of', 'progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Eng J Med', '307:652-659, 1982', '18.', 'Lichtman SM, Wildiers H, Launay-Vacher V, et al: International Society of Geriatric Oncology', '(SIOG) recommendations for the adjustment of dosing in elderly cancer patients with renal', 'insufficiency. Eur J Cancer 43:14-34, 2007', '19.', 'Hurria A, Lichtman SM: Pharmacokinetics of Chemotherapy in the Older Patient. Cancer Control', '14:32-43, 2007', '20.', 'Baker S, Grochow L: Pharmacology of chemotherapy in the older person. Clin Geriatr Med', '13:169-183, 1997', '21.', 'Crome P, Flanagan R: Pharmacokinetic studies in elderly people. Pharmacokine 26:243-247,', '1994', '77', 'NCIVersion Date: 5/29/2020', 'Update 5']\n\n###\n\n", "completion": "END"}